Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
Bioequivalence and the Tolerability and Antitumor Activity of Selinexor Combination Treatment

During the Combination Therapy Period, the safety and preliminary anti-tumor activity of selinexor in combination with docetaxel (for patients with NSCLC) or pembrolizumab (for patients with CRC) will be evaluated.

pembrolizumab
monoclonal antibodies
non-small cell lung cancer
fluorouracil
selinexor
  • 0 views
  • 16 Feb, 2024
  • 3 locations
Intravesical Gemcitabine and Docetaxel for BCG na ve Non-muscle Invasive Bladder Cancer

A tolerable safety profile and demonstrated efficacy would support a potential, randomized phase 3 trial comparing the experimental combination therapy and standard of care intravesical BCG therapy.

bacillus calmette-guerin
combined modality therapy
hormone levels
luteinizing hormone
bladder carcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation

The present ACCO (Adenoid Cystic Carcinoma and Carbon ion Only irradiation) study, a prospective, open-label, phase II, single-arm, investigator-initiated study, will therefore investigate the sole radiotherapy of carbon ions in this tumor entity. Irradiation is applied - significantly shorter than the combination therapy - in about 4 weeks (22 fractions); …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will concurrently enroll patients with four distinct advanced malignancies in 5 separate tumor cohorts. The four cancers type are NSCLC and melanoma that are progressing …

metastasis
monoclonal antibodies
non-small cell lung cancer
melanoma
stage iv nsclc
  • 0 views
  • 16 Feb, 2024
  • 9 locations
Combination Immunotherapy Targeting Sarcomas

The aim of this clinical trial is to assess the feasibility, safety and efficacy of a combination low dose chemotherapy and immunotherapy in patients who have sarcoma that is relapsed or late staged. Another goal of the study is to assess the safety and efficacy of the therapy that combines …

kidney function tests
immunosuppressive
sarcoma
recurrent sarcoma
creatinine clearance rate
  • 0 views
  • 16 Feb, 2024
  • 2 locations
Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder

The purpose of this study is to determine if Liposom Forte will enhance the response to antidepressant therapy with citalopram in elderly patients suffering from Major Depressive Disorder (MDD).

  • 0 views
  • 11 Oct, 2021
  • 16 locations
Safety Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831

The clinical study is designed to evaluate the safety, tolerability and pharmacokinetics of inhaled nanoparticle nanoparticle formulation of Remdesivir (GS-5734) alone and in combination with NA-831 in 48 healthy volunteers.

immunodeficiency
hysterectomy
tubal ligation
hepatitis
remdesivir
  • 0 views
  • 16 Feb, 2024
  • 1 location
Ipatasertib + Atezolizumab to Prevent Recurrence in TNBC

The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer in the breast or lymph nodes and have circulating tumor DNA in the blood. This research study involves the following investigational drugs: Ipatasertib Atezolizumab

ipatasertib
absolute lymphocyte count
anticoagulants
gilbert's syndrome
immunomodulators
  • 0 views
  • 16 Feb, 2024
  • 1 location
CIML NK Cell in Head & Neck Cancer

This research study is evaluating the safety and efficacy of a combination drug and biologic therapy in patients with advanced head and neck cancer. This research study involves the following drugs and biologics: CIML NK donor cells IL-15 superagonist Ipilimumab

biological therapy
caries
steroid therapy
metastatic squamous cell carcinoma
carcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients (EEBC)  

The elderly patients over 65 years old with breast cancer have concomitant diseases, poor tolerance to conventional treatment, and the specific prognosis of breast cancer is relatively good. Previous studies on breast cancer have almost excluded elderly breast cancer patients, and conventional treatment schemes cannot meet the clinical diagnosis and …

  • 0 views
  • 16 Jun, 2023
  • 1 location